SCHEMBL2190212

SCHEMBL2190212

CC(C)([C@@H]1CCN(c2ccc(-c3cnc[n+](OC(=O)C(F)(F)F)c3)cc2)C(=O)C1)S(=O)(=O)c1cccc(C(F)(F)F)c1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CACNA1B Q00975 3/20 0.42
CYP3A4 P08684 3/20 0.42
NR1I2 O75469 1/20 0.40
KMT2A Q03164 2/20 0.34
CTPS1 P17812 2/20 0.33
CNR1 P21554 1/20 0.33
RAF1 P04049 1/20 0.33
BRAF P15056 1/20 0.33
L3MBTL1 Q9Y468 2/20 0.33
GRM5 P41594 1/20 0.33
FPR2 P25090 3/20 0.32
POLB P06746 1/20 0.32
RORC P51449 1/20 0.32
FPR1 P21462 2/20 0.32
MEN1 O00255 1/20 0.32
LMNA P02545 1/20 0.32
MAPT P10636 1/20 0.32
TSHR P16473 1/20 0.32
MAPK1 P28482 1/20 0.32
SMN1; SMN2 Q16637 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2194150 1.00 CACNA1B (0.42) CACNA1BCYP3A4NR1I2KMT2ACTPS1
SCHEMBL2187773 0.89 CACNA1B (0.43) CACNA1BCYP3A4NR1I2KMT2ACTPS1
SCHEMBL2192775 0.89 CACNA1B (0.43) CACNA1BCYP3A4NR1I2KMT2ACTPS1
Trifluoroacetic Acid SCHEMBL2190207 0.84 CACNA1B (0.44) CACNA1BCYP3A4NR1I2KMT2ACTPS1
Trifluoroacetic Acid SCHEMBL2194144 0.84 CACNA1B (0.44) CACNA1BCYP3A4NR1I2KMT2ACTPS1
SCHEMBL12415578 0.84 CYP3A4 (0.43) CACNA1BCYP3A4NR1I2KMT2ACNR1
SCHEMBL12415571 0.84 CYP3A4 (0.43) CACNA1BCYP3A4NR1I2KMT2ACNR1
Trifluoroacetic Acid SCHEMBL2192773 0.83 CYP11B1 (0.43) CACNA1BCYP3A4NR1I2CTPS1FPR2
Trifluoroacetic Acid SCHEMBL2187768 0.83 CYP11B1 (0.43) CACNA1BCYP3A4NR1I2CTPS1FPR2
SCHEMBL12415565 0.82 CYP11B1 (0.47) CACNA1BCYP3A4NR1I2KMT2ACTPS1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110172236-A1 SUBSTITUTED ARYL SULFONE DERIVATIVES AS CALCIUM CHANNEL BLOCKERS CHAKRAVARTY PRASUN K 2011-07-14 US claimed
US-20110172236-A1 SUBSTITUTED ARYL SULFONE DERIVATIVES AS CALCIUM CHANNEL BLOCKERS CHAKRAVARTY PRASUN K 2011-07-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110172236-A1 SUBSTITUTED ARYL SULFONE DERIVATIVES AS CALCIUM CHANNEL BLOCKERS TRPV1, TRPA1, CACNA1D CACNA1B 23/4885CYP3A4 939/4885NR1I2 765/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.